The American Journal of Pathology
Volume 180, Issue 4 , Pages 1441-1453, April 2012

Hedgehog-Gli Pathway Activation during Kidney Fibrosis

  • Steven L. Fabian

      Affiliations

    • Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts
  • ,
  • Radostin R. Penchev

      Affiliations

    • Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts
  • ,
  • Benoit St-Jacques

      Affiliations

    • Institute for Research in Immunology and Cancer, University of Montreal, Montreal, Quebec, Canada
  • ,
  • Anjali N. Rao

      Affiliations

    • Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts
  • ,
  • Petra Sipilä

      Affiliations

    • Department of Physiology, Institute of Biomedicine, University of Turku, Finland
  • ,
  • Kip A. West

      Affiliations

    • Infinity Pharmaceuticals, Cambridge, Massachusetts
  • ,
  • Andrew P. McMahon

      Affiliations

    • Harvard Stem Cell Institute, Holyoke Center, Cambridge, Massachusetts
    • Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts
    • Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts
  • ,
  • Benjamin D. Humphreys

      Affiliations

    • Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts
    • Harvard Stem Cell Institute, Holyoke Center, Cambridge, Massachusetts
    • Corresponding Author InformationAddress reprint requests to Benjamin D. Humphreys, M.D., Ph.D., Harvard Institutes of Medicine Room 554, 4 Blackfan Circle, Boston, MA 02115

Accepted 29 December 2011. published online 20 February 2012.

The Hedgehog (Hh) signaling pathway regulates tissue patterning during development, including patterning and growth of limbs and face, but whether Hh signaling plays a role in adult kidney remains undefined. In this study, using a panel of hedgehog-reporter mice, we show that the two Hh ligands (Indian hedgehog and sonic hedgehog ligands) are expressed in tubular epithelial cells. We report that the Hh effectors (Gli1 and Gli2) are expressed exclusively in adjacent platelet-derived growth factor receptor-β-positive interstitial pericytes and perivascular fibroblasts, suggesting a paracrine signaling loop. In two models of renal fibrosis, Indian Hh ligand was upregulated with a dramatic activation of downstream Gli effector expression. Hh-responsive Gli1-positive interstitial cells underwent 11-fold proliferative expansion during fibrosis, and both Gli1- and Gli2-positive cells differentiated into α-smooth muscle actin-positive myofibroblasts. In the pericyte-like cell line 10T1/2, hedgehog ligand triggered cell proliferation, suggesting a possible role for this pathway in the regulation of cell cycle progression of myofibroblast progenitors during the development of renal fibrosis. The hedgehog antagonist IPI-926 abolished Gli1 induction in vivo but did not decrease kidney fibrosis. However, the transcriptional induction of Gli2 was unaffected by IPI-926, suggesting the existence of smoothened-independent Gli activation in this model. This study is the first detailed description of paracrine hedgehog signaling in adult kidney, which indicates a possible role for hedgehog-Gli signaling in fibrotic chronic kidney disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the NIH (RO1 DK088923 to B.D.H. and T32 training grant DK007527 to S.L.F) and the Harvard Stem Cell Institute (B.D.H).

 Disclosures: K.A.W. holds stock options or bond holdings in a for-profit corporation or self-directed pension plan (Infinity Pharmaceuticals) and is also a full-time employee of Infinity Pharmaceuticals. None of the other authors disclosed any conflict of interest.

 Supplemental material for this article can be found on http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.12.039.

PII: S0002-9440(12)00087-9

doi:10.1016/j.ajpath.2011.12.039

The American Journal of Pathology
Volume 180, Issue 4 , Pages 1441-1453, April 2012